knowledge -WSS

knowledge

author：knowledge 2025-10-01 18:32:20 - browse：7

A sign of Elevance Health behind some flowers — coverage from STAT — Michael Conroy/AP

These days, the surefire way to get ahead in health insurance is to become a health care provider, and Elevance just upped the ante. It’s joining with private equity to launch a $4 billion primary care company.

Elevance leaders divulged more about the company’s venture with Clayton, Dubilier & Rice on its first quarter earnings call Thursday. The partners announced the new company, yet unnamed, earlier this week, but the release was light on detail. The strategic partnership will house Elevance and CD&R’s doctors, clinics, and the technologies that help those doctors manage their patients.

Health insurers specialize in managing medical costs, and through ventures like this, they apply that expertise to managing patients’ chronic medical conditions. In arrangements like Medicare Advantage, where insurers are paid set amounts for members’ care, they’re incentivized to keep those patients healthy.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Medicare Advantage coverage denials need scrutiny, senators say

WSS

California wildfire smoke linked to 52,000 early deaths, study says

Moderna says combo Covid

How the BIOSECURE Act is already affecting U.S., Chinese life science firms

Teladoc has a new CEO, but challenges remain the same

Fauci's latest grilling in Congress: 9 hours, behind closed doors

Profiling embryos to choose those with higher IQs is almost a reality

knowledge

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

Wikipedia

Walensky prepares to leave CDC — and Congress — behind

Profiling embryos to choose those with higher IQs is almost a reality

Dobbs anniversary: the lost opportunity of abortion as health care

Heat wave can put hearts into ‘oxygen debt,' lab experiment shows

Supreme Court strikes down use of affirmative action

In shift, Texas to cover initial consult for Afghan baby's gene therapy

FDA approval of Sarepta Duchenne genetic therapy gives me hope

In shift, Texas to cover initial consult for Afghan baby's gene therapy

After affirmative action ruling, medical educators look to 'holistic review'

Readers discuss the intersection of pregnancy and addiction

leisure time

Readout Newsletter: Cytokinetics and Novartis' starcrossed tale

Medicare Advantage overpayments discussion gets experts fired up

Cancer thrives by mutating. But sometimes, a mutation leaves it vulnerable

Readers discuss the intersection of pregnancy and addiction

Boston Scientific acquires urology company Axonics for $3.7 billion

FDA reviewers ask if approval of Lilly’s Alzheimer’s drug should be restricted

entertainment

hotspot

hotspot

focus